Aprea Therapeutics to Present at October Conferences
Aprea Therapeutics, a clinical-stage oncology company developing targeted therapies for biomarker-defined cancers, announced that CEO Oren Gilad will participate in the 2026 Maxim Growth Summit and Regional Biotechnology Conference. The company emphasizes its precision medicine approach aiming to exploit cancer cell vulnerabilities while minimizing…